SAB Biotherapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BVF INC/IL | 08/14/2025 | 917.83 K | $1.61 M | 0.00% | 9.88% |
| SESSA CAPITAL IM, L.P. | 08/13/2025 | 458.46 K | $804.59 K | 0.00% | 4.93% |
| VANGUARD GROUP INC | 08/11/2025 | 282.37 K | $494.15 K | 1.75% | 3.04% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/08/2025 | 84.77 K | $148.37 K | 0.10% | 0.91% |
| PATHSTONE HOLDINGS, LLC | 08/12/2025 | 50.65 K | $88.89 K | 0.00% | 0.54% |
| KOVITZ INVESTMENT GROUP PARTNERS, LLC | 08/14/2025 | 19.20 K | $33.70 K | 0.00% | 0.21% |
| FIRST PREMIER BANK | 07/11/2025 | 18.99 K | $33.00 K | 0.00% | 0.20% |
| CITADEL ADVISORS LLC | 08/14/2025 | 17.10 K | $29.92 K | 100.00% | 0.18% |
| KESTRA ADVISORY SERVICES, LLC | 08/15/2025 | 11.93 K | $20.94 K | 0.00% | 0.13% |
| CREATIVE PLANNING | 08/08/2025 | 11.85 K | $20.80 K | 100.00% | 0.13% |
| NORTHERN TRUST CORP | 08/13/2025 | 11.39 K | $19.98 K | 0.00% | 0.12% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2025 | 11.03 K | $19.36 K | 9.97% | 0.12% |
| UBS GROUP AG | 08/14/2025 | 10.66 K | $18.71 K | 13,564.10% | 0.11% |
| BLACKROCK, INC. | 08/12/2025 | 7.01 K | $12.30 K | -68.58% | 0.08% |
| ADVISOR GROUP HOLDINGS, INC. | 09/04/2025 | 4.94 K | $8.64 K | -0.20% | 0.05% |
| SACHETTA, LLC | 07/23/2025 | 4.10 K | $7.20 K | 0.00% | 0.04% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/15/2025 | 726 | $1.27 K | 2,035.29% | 0.01% |
| MAI CAPITAL MANAGEMENT | 08/12/2025 | 217 | $381 | 0.00% | 0.00% |
| GS INVESTMENTS, INC. | 08/07/2025 | 200 | $351 | 0.00% | 0.00% |
| MORGAN STANLEY | 08/15/2025 | 168 | $295 | -62.58% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2025 | 87 | $152 | -15.53% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 08/14/2025 | 73 | $128 | 8.96% | 0.00% |
| HARBOUR INVESTMENTS, INC. | 07/28/2025 | 50 | $88 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 08/08/2025 | 50 | $88 | 0.00% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 08/14/2025 | 45 | $79 | 100.00% | 0.00% |
| SILVER OAK SECURITIES, INCORPORATED | 07/11/2025 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2025 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 08/12/2025 | 0 | $0 | -100.00% | 0.00% |
| HB WEALTH MANAGEMENT, LLC | 07/17/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
SAB Biotherapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 34 institutional investors and hedge funds held shares of SAB Biotherapeutics, Inc.. The most heavily invested institutionals were:
BVF INC/IL: 917,826
Sessa Capital IM, L.P.: 458,457
VANGUARD GROUP INC: 282,371
GEODE CAPITAL MANAGEMENT, LLC: 84,772
Pathstone Holdings, LLC: 50,650
Kovitz Investment Group Partners, LLC: 19,201
20.70% of SAB Biotherapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 2.97 M shares in the last 24 months. This purchase volume represents approximately $6.99 M in transactions.